ATE451931T1 - Intranasale influenza-vakzine auf basis von virosomen - Google Patents

Intranasale influenza-vakzine auf basis von virosomen

Info

Publication number
ATE451931T1
ATE451931T1 AT07727166T AT07727166T ATE451931T1 AT E451931 T1 ATE451931 T1 AT E451931T1 AT 07727166 T AT07727166 T AT 07727166T AT 07727166 T AT07727166 T AT 07727166T AT E451931 T1 ATE451931 T1 AT E451931T1
Authority
AT
Austria
Prior art keywords
virosomes
influenza vaccine
vaccine based
intranasal influenza
intranasal
Prior art date
Application number
AT07727166T
Other languages
English (en)
Inventor
Alexander J Kersten
Lisya Gerez
Pieter J Schoen
Jozef J P Nauta
Rheineck Leyssius Dorine H Van
Original Assignee
Solvay Biologicals Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Biologicals Bv filed Critical Solvay Biologicals Bv
Application granted granted Critical
Publication of ATE451931T1 publication Critical patent/ATE451931T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT07727166T 2006-03-22 2007-03-21 Intranasale influenza-vakzine auf basis von virosomen ATE451931T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78446206P 2006-03-22 2006-03-22
EP06111534 2006-03-22
PCT/EP2007/052690 WO2007107585A1 (en) 2006-03-22 2007-03-21 Intranasal influenza vaccine based on virosomes

Publications (1)

Publication Number Publication Date
ATE451931T1 true ATE451931T1 (de) 2010-01-15

Family

ID=38038698

Family Applications (2)

Application Number Title Priority Date Filing Date
AT09178084T ATE539766T1 (de) 2006-03-22 2007-03-21 Intranasale influenzaimpfstoffe aus virosomen
AT07727166T ATE451931T1 (de) 2006-03-22 2007-03-21 Intranasale influenza-vakzine auf basis von virosomen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT09178084T ATE539766T1 (de) 2006-03-22 2007-03-21 Intranasale influenzaimpfstoffe aus virosomen

Country Status (21)

Country Link
EP (2) EP2158921B1 (de)
JP (1) JP5285595B2 (de)
KR (1) KR20090016659A (de)
AR (1) AR059972A1 (de)
AT (2) ATE539766T1 (de)
AU (1) AU2007228736B2 (de)
BR (1) BRPI0709864A2 (de)
CA (1) CA2646895A1 (de)
DE (1) DE602007003815D1 (de)
DK (2) DK1996229T3 (de)
EA (1) EA014532B1 (de)
ES (2) ES2338382T3 (de)
HR (2) HRP20100144T1 (de)
IL (1) IL193840A (de)
MY (1) MY142996A (de)
NO (1) NO20084452L (de)
PL (2) PL1996229T3 (de)
PT (2) PT2158921E (de)
SA (1) SA07280116B1 (de)
SI (2) SI1996229T1 (de)
WO (1) WO2007107585A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2011107757A (ru) * 2008-08-01 2012-09-10 Гамма Ваксинс Пти Лимитед (Au) Вакцины против гриппа
KR20130140050A (ko) * 2010-11-02 2013-12-23 헥토 마뉴엘 제페다 로페즈 Ａ/ｈ1ｎ1 범유행 인플루엔자 바이러스에 대한 신규한 백신
US11523988B2 (en) 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018690D0 (en) * 1990-08-24 1990-10-10 Wellcome Found Vaccines
EP1447080A1 (de) * 2003-02-13 2004-08-18 Bestewil Holding B.V. Methode zur Herstellung von Virosomen-artigen Partikeln
AR056245A1 (es) * 2003-06-19 2007-10-03 Bestewil Holding Bv Membranas virales reconstituidas funcionales que contienen un coadyuvante

Also Published As

Publication number Publication date
HRP20100144T1 (hr) 2010-04-30
PT1996229E (pt) 2010-03-16
SI2158921T1 (sl) 2012-03-30
JP5285595B2 (ja) 2013-09-11
AU2007228736B2 (en) 2011-12-15
PL1996229T3 (pl) 2010-05-31
CA2646895A1 (en) 2007-09-27
EP2158921A1 (de) 2010-03-03
HRP20120013T1 (hr) 2012-01-31
DE602007003815D1 (en) 2010-01-28
BRPI0709864A2 (pt) 2011-07-26
DK1996229T3 (da) 2010-05-03
JP2009530351A (ja) 2009-08-27
AU2007228736A1 (en) 2007-09-27
SI1996229T1 (sl) 2010-04-30
EA200870361A1 (ru) 2009-02-27
IL193840A (en) 2011-10-31
SA07280116B1 (ar) 2010-10-19
IL193840A0 (en) 2011-08-01
MY142996A (en) 2011-02-14
ES2338382T3 (es) 2010-05-06
KR20090016659A (ko) 2009-02-17
EP2158921B1 (de) 2012-01-04
EP1996229A1 (de) 2008-12-03
ES2375436T8 (es) 2012-03-15
DK2158921T3 (da) 2012-05-07
PT2158921E (pt) 2012-03-27
EP1996229B1 (de) 2009-12-16
NO20084452L (no) 2008-10-22
ATE539766T1 (de) 2012-01-15
WO2007107585A1 (en) 2007-09-27
EA014532B1 (ru) 2010-12-30
PL2158921T3 (pl) 2012-06-29
AR059972A1 (es) 2008-05-14
ES2375436T3 (es) 2012-02-29

Similar Documents

Publication Publication Date Title
DK2422810T3 (da) Influenzavaccine
ATE450271T1 (de) Impfstoff
DK1926496T3 (da) PCV-2-vaccine
DK2200646T3 (da) RNA-Vacciner
DK1968631T3 (da) Vaccine
DK2069503T3 (da) Papayamosaikvirus-baserede vacciner mod influenza
BRPI0922878A2 (pt) ventilador
DK2114993T3 (da) Vaccine
CR10571A (es) Vacuna virica recombinante
BRPI0909770A2 (pt) Vacina, e, kit
BRPI0821034A2 (pt) Vírus influenza modificado
IL196024A0 (en) Influenza vaccine
DK1942933T3 (da) Hundeinfluenzavacciner
BRPI1014844A2 (pt) variantes de hemaglutinina de influenza suína.
SMT201400170B (it) Vaccino contro hpv
ATE451931T1 (de) Intranasale influenza-vakzine auf basis von virosomen
DK1877549T3 (da) HIV-vaccine
DK2175881T3 (da) Intradermal influenzavaccine
HK1128077A1 (en) Intranasal influenza vaccine based on virosomes
ZA200900062B (en) Influenza vaccine
CN301053852S (zh) 夹扇夹子(ftw18-8k)
SE0602183L (sv) Luftvärmepanna
ITBS20060055A1 (it) Depuratore aria
CN301140860S (zh) 风扇底座(十字架)
ES1068193Y (es) Expositor de piezas ceramicas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1996229

Country of ref document: EP

EEFA Change of the company name